| abstract |
Compounds having NEP-inhibitory activity, corresponding to the formula I in which n R 1 is hydrogen or a group forming a biolabile phosphonic acid ester, n R 2 is hydrogen or a group forming a biolabile phosphonic acid ester and n R 3 is hydrogen or a group forming a biolabile carboxylic acid ester n and physiologically acceptable salts of acids of formula I, and pharmaceutical compositions comprising these compounds. |